Table 4 Late cardiotoxicity in patients... | American Society of Hematology

Table 4

Late cardiotoxicity in patients treated with L-DNR and idarubicin

	L-DNR	Idarubicin
n	170	185
CTC score I	9	10
After relapse/HSCT*	4	3
No relapse/no HSCT and CTC score I only once*	5	6†
No relapse/no HSCT and CTC score I present >6 mo	0	1
CTC score III/IV	2	3
After relapse/HSCT*	1‡	1
No relapse/no SCT and CTC score III/IV present >6 mo	1	2
Total: No relapse/no HSCT and CTC score I-IV present >6 mo	1	3

	L-DNR	Idarubicin
n	170	185
CTC score I	9	10
After relapse/HSCT*	4	3
No relapse/no HSCT and CTC score I only once*	5	6†
No relapse/no HSCT and CTC score I present >6 mo	0	1
CTC score III/IV	2	3
After relapse/HSCT*	1‡	1
No relapse/no SCT and CTC score III/IV present >6 mo	1	2
Total: No relapse/no HSCT and CTC score I-IV present >6 mo	1	3

There were no CTC II cardiotoxicities.

Excluded for the calculation of induction-related cardiotoxicity.

One patient refused follow-up.

Patient died 7 days after HSCT with sepsis and cardiac failure.